J. Vachiery (Brussels, Belgium), J. Pepke-Zaba (Cambridge, United Kingdom), A. Ghofrani (Giessen, Germany), I. Preston (Boston, United States of America)
PLA2 polymorphism of platelet glycoprotein IIb/IIIa but not Factor V Leiden and prothrombin G20210A polymorphisms is associated with venous thromboembolism and more recurrent events
H. Rouhi Boroujeni, B. Pourgheysari, A. Hasheminia (Shahrekord, Islamic Republic Of Iran)
|   |
Tetrahydrobioptherin improves pulmonary vascular remodeling following mouse-intratraqueal bleomicin administration
P. Almudever, R. Guijarro, J. Milara, K. Marini, J. Cortijo (Valencia, Spain)
| |
Molecular analysis of genes BMPR2 and KCNA5 in Spanish patients with pulmonary arterial hypertension
G. Pousada, A. Baloira, C. Vilariño, D. Valverde (Pontevedra, Vigo, Spain)
| |
The German version of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) – Four-stage translation and validation
K. Cima, J. Twiss, R. Speich, S.P. McKenna, E. Grunig, C.M. Kähler, N. Ehlken, U. Treder, S.R. Crawford, L.C. Huber, S. Ulrich (Innsbruck, Austria; Manchester, United Kingdom; Zurich, Switzerland; Heidelberg, Germany)
| |
Reference values for the 6-minute walk test in healthy children
S. Ulrich, F. Hildenbrand, U. Treder, M. Fischler, R. Speich, M. Fastnacht (Zurich, Switzerland)
| |
The adenosine A2B receptor antagonist GS-6201 reduces small artery muscularization and plasma endothelin-1 in a short term cigarette smoke exposure model
J. Wright, H. Zhong, D. Zeng, L. Belardinelli, A. Churg (Vancouver, Canada; Palo Alto, United States Of America)
| |
End-tidal CO2 pressure may facilitate differential diagnostics between PH patients with chronic heart or lung disease and CTEPH
M. Tscherner, G. Kovacs, V. Foris, S. Scheidl, A. Avian, A. Olschewski, H. Olschweski (Graz, Austria)
| |
Human pentraxin 3 (PTX3) as a novel biomarker for the diagnosis of pulmonary arterial hypertension
Y. Tamura, M. Kuwana, K. Inoue, T. Ono, M. Takei, T. Yamamoto, M. Kataoka, M. Sano, T. Satoh, K. Fukuda (Tokyo, Japan)
| |
Acute vasoreactivity testing with sildenafil vs nitric oxide in patients with PAH
K. Milger, H. Tiede, J. Felix, F. Grimminger, W. Seeger, H. Ghofrani (Giessen, Germany; Rotterdam, Netherlands)
| |
The clinical role of routine non-invasive parameters in the diagnostic work-up of patients with risk for pulmonary hypertension
G. Kovacs, V. Foris, M. Tscherner, A. Avian, X. Kqiku, A. Olschewski, H. Olschewski (Graz, Austria)
| |
Patients‘, relatives‘ and practitioners‘ views on pulmonary arterial hypertension
S. Alami, V. Cottin, D. Desjeux, L. Mouthon, S. Poiraudeau, E. Quessette, O. Sitbon (Paris, Lyon, Suresnes, Clamart, France)
| |
A slower life in a smaller world. Patients‘ perspective on living with pulmonary arterial hypertension
A. Mulgirigama, D. Hunt, R. Wilson, J. Pepke-Zaba (Tadworth, Papworth Everard, United Kingdom)
| |
Exhaled nitric oxide in reactive pulmonary hypertenzion
C. Bucca, P. Omedè, W. Grosso Marra, I. Parisi, A. Vaudano, M. Malandra, M. Masoero, L. Brussino, C. Magnino (Turin, Torino, Italy)
| |
Unique hemodynamic profile of HIV patients with portal hypertension: Comparison with HIV-associated PAH and porto-pulmonary hypertension
M. Nigo, G. Tulliano, R. Sulica (New York, United States Of America)
| |
Cardiac index by thermodilution and from non-invasive pulse pressure profiles analysis in PAH
F. Lador, O. Sitbon, G. Simonneau, P. Hervé (Geneva, Switzerland; Clamart, Le Plessis-Robinson, France)
| |
Heart rate variability: Possible implications for management of pulmonary arterial hypertension patients
K. Semen, L. Solovey, M. Karapinka, O. Yelisyeyeva (Lviv, Ukraine)
| |
Impact of a wireless implanted pulmonary artery pressure monitoring system in heart failure patients with comorbid chronic obstructive pulmonary disease
G. Criner, R. Bourge, R. Benza, P. Adamson, W. Abraham, J. Yadav, B. Jeffries, P. Cowart, J. Bauman, F. Martinez (Philadelphia, Pittsburgh, Columbus, Oklahoma City, Atlanta, Ann Arbor, United States Of America)
| |
Is nailfold videocapillaroscopy a valuable diagnostic tool in pulmonary hypertension?
F. Meier, M. Geyer, H. Tiede, A. Rieth, H.A. Ghofrani, U. Müller-Ladner, R. Dinser, W. Hermann (Bad Nauheim, Giessen, Germany)
| |
Right ventricular global strain and right ventricular dyssynchrony can predict success to pulmonary vasodilators therapy in PH patients
B. Lamia, L.C. Molano, C. Viacroze, A. Cuvelier, J.F. Muir (Rouen, France)
| |
Role of C-terminal pro-endothelin in pulmonary hypertension
R. Kaiser, P.M. Lepper, R. Bals, H. Wilkens (Homburg/Saar, Germany)
| |